Formulation and in vitro evaluation of a siRNA delivery nanosystem decorated with gH625 peptide for triple negative breast cancer theranosis - Archive ouverte HAL Access content directly
Journal Articles European Journal of Pharmaceutics and Biopharmaceutics Year : 2018

Formulation and in vitro evaluation of a siRNA delivery nanosystem decorated with gH625 peptide for triple negative breast cancer theranosis

(1) , (1) , (1) , (2) , (3) , (1) , (1) , (1)
1
2
3

Domains

Life Sciences [q-bio] Biochemistry, Molecular Biology Life Sciences [q-bio] Cancer Life Sciences [q-bio] Bioengineering

Martin Soucé  : Connect in order to contact the contributor

https://hal-univ-tours.archives-ouvertes.fr/hal-01919906

Submitted on : Monday, November 12, 2018-5:58:36 PM

Last modification on : Wednesday, November 30, 2022-4:14:07 PM

Consult the full text

Dates and versions

hal-01919906 , version 1 (12-11-2018)

Identifiers

Cite

Sanaa Ben Djemaa, Stephanie David, Katel Hervé-Aubert, Annarita Falanga, Stefania Galdiero, et al.. Formulation and in vitro evaluation of a siRNA delivery nanosystem decorated with gH625 peptide for triple negative breast cancer theranosis. European Journal of Pharmaceutics and Biopharmaceutics, 2018, 131, pp.99 - 108. ⟨10.1016/j.ejpb.2018.07.024⟩. ⟨hal-01919906⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

UNIV-TOURS
51 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More